for some people, they can't afford to wait

plus,

you can't patent aspirin for anything even if you work out the biochemical mechanism.

Yes, the conclusion about cancer preventive benefit derived from statistical meta-analysis, so nothing was there about a mechanistic study.

This much we know - it's a cox inhibitor, largely cuts off prostaglandins synthesis. Current food supplies are just too rich in precursors for PGs. 

Personally, I think safety profile of aspirin is at least one magnitude better than selective cox2 inhibitors.

所有跟帖： 

• 阿司匹林造成出血的病例临床上很多的，你最好不要推荐这种药物！ -^3.1415926^- ♂ (41 bytes) () 02/14/2012 postreply 12:09:08

• 在中国仍是处方药。 -^3.1415926^- ♂ (227 bytes) () 02/15/2012 postreply 10:51:45